Koninklijke Philips N.V. ADR (PHG)
NYSE
Closed
Oct 7, 2026
Day's Range
24.0452 wk Range
23.62Overview - PHG - Koninklijke Philips N.V. ADR
Key Statistics
Valuation
Enterprise Value
32.67B
P/E (Trailing)
‪18.54‬
P/E (Forward)
‪12.60‬
PEG Ratio
‪0.30‬
Price / Sales (TTM)
‪1.32‬
Price / Book
‪1.80‬
EV / EBITDA
‪12.03‬
Profitability
Gross Margin
‪49.31%‬
Profit Margin
‪6.30%‬
Operating Margin
‪13.99%‬
Return on Assets
‪4.06%‬
Return on Equity
‪10.15%‬
Ownership
Shares Outstanding
977.42M
Float
976.61M
Held by Insiders
‪0.00%‬
Held by Institutions
‪5.41%‬
Price stats
Beta
‪0.91‬
50-Day Avg
‪25.97‬
200-Day Avg
‪27.44‬
Dividends
Payout Ratio
‪76.21%‬
Analyst Consensus
5 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PHG - Koninklijke Philips N.V. ADR
Peers - PHG - Koninklijke Philips N.V. ADR
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - PHG - Koninklijke Philips N.V. ADR
About
Koninklijke Philips N.V. ADR is a global health technology company focused on developing products and solutions for diagnosis and treatment, connected care, and personal health. Its portfolio includes medical imaging systems, ultrasound equipment, image-guided therapy tools, patient monitoring systems, sleep and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
